The global pharmaceutical logistics market size was valued at USD 109.89 billion in 2025 and is projected to grow from USD 119.56 billion in 2026 to USD 234.76 billion by 2034, registering a CAGR of 8.8% during the forecast period from 2026 to 2034. Europe dominated the pharmaceutical logistics market with a market share of 34% in 2025.
Pharmaceutical logistics refers to the coordinated processes involved in storing, handling, transporting, and delivering medicines, vaccines, medical products, and other pharmaceutical supplies. It ensures that products are maintained under appropriate conditions throughout their journey from manufacturers to distributors, pharmacies, hospitals, and patients. Pharmaceutical logistics includes inventory management, temperature-controlled storage and transportation, packaging, tracking, order fulfillment, and regulatory documentation. These activities help preserve product quality, prevent damage or contamination, ensure timely delivery, and maintain the safety and integrity of pharmaceutical products.
Download a Free Sample To learn more about this report,
Cold-Chain Infrastructure Expands for Temperature-Sensitive Medicines
The pharmaceutical logistics market is changing as more medicines require controlled temperatures during storage and transportation. Vaccines, biologics, specialty medicines, and cell and gene therapies need carefully managed conditions to maintain their quality from manufacturing facilities to patients. Logistics companies are therefore expanding refrigerated warehouses, temperature-controlled vehicles, specialized packaging, and monitoring systems. This is supporting pharmaceutical logistics market growth as pharmaceutical supply chains become more specialized.
Real-Time Visibility Improves Pharmaceutical Shipment Management
Pharmaceutical companies and logistics providers are increasingly using digital tracking, temperature sensors, and centralized control towers to monitor shipments throughout their journey. Real-time information can help logistics teams identify temperature deviations, delays, and other issues before they affect product quality. This move toward connected supply chains is contributing to the increasing pharmaceutical logistics market size and improving shipment reliability.
Growing Demand for Temperature-Controlled Pharmaceutical Distribution
The market is being driven by the increasing need to move vaccines, biologics, specialty medicines, and other temperature-sensitive products safely from manufacturers to patients. These products require carefully controlled storage and transportation conditions, increasing demand for cold-chain warehouses, specialized packaging, monitoring systems, and validated transportation. WHO states that temperature mapping and monitoring are integral to maintaining appropriate pharmaceutical storage conditions.
High Cost of Cold-Chain Infrastructure and Specialized Handling
The market faces pressure from the cost of maintaining refrigerated warehouses, temperature-controlled vehicles, monitoring equipment, specialized packaging, backup power, and trained personnel. Pharmaceutical logistics providers must also demonstrate that products remain within specified conditions throughout storage and transportation, adding to operational complexity. WHO guidance emphasizes systematic temperature mapping of cold rooms, freezers, refrigerators, and dry-storage areas to identify temperature variations that could affect pharmaceutical products.
Expansion of Biologics, Cell and Gene Therapies, and Advanced Cold Chains
The market has strong opportunities as pharmaceutical pipelines increasingly include biologics, specialty medicines, vaccines, and cell and gene therapies requiring highly controlled logistics. These products create demand for specialized packaging, real-time monitoring, dedicated transportation, and end-to-end visibility, making advanced cold-chain capabilities an important pharmaceutical logistics market trend.
Maintaining Product Integrity During Long and Disrupted Supply Chains
The market continues to face challenges from transportation delays, extreme temperatures, geopolitical disruptions, capacity shortages, and increasingly complex regulatory requirements. These risks can be particularly significant for high-value and temperature-sensitive medicines, where maintaining product integrity throughout the entire journey is essential.
Non-Cold Chain Logistics Segment Led the Market with a 58% Share in 2025
Non-cold chain logistics accounted for the largest share of the pharmaceutical logistics market in 2025, representing 58% and an estimated value of $63.74 billion. This segment covers the movement and storage of pharmaceutical products that do not require tightly controlled temperatures. It remains important because a large volume of medicines, medical supplies, and pharmaceutical products can be transported under standard conditions. Growing pharmaceutical production and expanding distribution networks are supporting demand for reliable non-cold chain logistics.
Cold chain logistics accounted for the remaining 42% of the market, valued at approximately $46.16 billion. This segment is particularly important for temperature-sensitive products such as vaccines, biologics, and certain specialty medicines. Although smaller in overall share, cold chain logistics is projected to grow at a faster 9.37% CAGR compared with non-cold chain logistics. Increasing use of biologic medicines and temperature-sensitive therapies is creating greater demand for controlled storage and transportation.
Request Customizationto receive a tailored report.
Monitoring Components Segment is Projected to Register the Fastest Growth at a CAGR of 9.41%
Monitoring components are projected to be the fastest-growing component category in the pharmaceutical logistics market, with a CAGR of 9.41% during 2026–2034. Real-time monitoring has become increasingly important for pharmaceutical shipments because companies need better visibility into temperature, location, humidity, and other conditions that can affect product quality. Sensors, tracking technologies, and connected monitoring systems allow logistics providers and pharmaceutical companies to identify potential problems earlier during transportation and storage.
Transportation represented the largest component segment at 49%, with a value of approximately $53.85 billion. Storage accounted for 36%, valued at around $39.56 billion. Within transportation, overland logistics represented 42%, followed by air freight at 31% and sea freight at 27%. In monitoring components, hardware accounted for 61%, while software represented 39%. Increasing adoption of connected sensors, RFID, telematics, and logistics-management software is helping pharmaceutical companies improve supply-chain visibility.
Storage Segment Led the Pharmaceutical Logistics Market with a 35% Share in 2025
Storage accounted for the largest share of the procedure segment in 2025, representing 35% and an estimated value of $38.46 billion. Pharmaceutical storage requires organized facilities and appropriate handling procedures to protect medicines throughout their distribution journey. Warehouses and specialized storage facilities play an important role in maintaining product quality before medicines reach healthcare providers, pharmacies, and other customers.
Handling systems accounted for 24% of the market, while picking represented 22%. Retrieval systems contributed 19%. As pharmaceutical supply chains become more complex, logistics providers are increasingly using automation, inventory-management systems, tracking technologies, and specialized handling processes to reduce errors and improve efficiency. The growing need to manage a wider range of medicines and pharmaceutical products is supporting investment across these procedures.
Bio-Pharma Segment is Projected to Register the Fastest Growth at a CAGR of 9.61%
The bio-pharma segment is projected to register the fastest growth in pharmaceutical logistics, with a CAGR of 9.61% during 2026–2034. Biologic medicines often require more specialized transportation and storage than conventional pharmaceutical products. Many are sensitive to temperature changes and handling conditions, increasing the need for dependable logistics networks, monitoring systems, and specialized packaging. Continued development and distribution of biologic therapies is therefore creating additional demand for advanced pharmaceutical logistics services.
Chemical pharma accounted for the largest share at 46%, representing approximately $50.55 billion. Bio-pharma followed with 38%, valued at around $41.76 billion, while specialized pharma represented 16%. Specialized pharmaceutical products often have more demanding handling and distribution requirements, creating opportunities for logistics providers that can offer customized storage, monitoring, and transportation solutions.
Roadways Segment Led the Pharmaceutical Logistics Market with a 34% Share in 2025
Roadways accounted for the largest share of pharmaceutical logistics operations in 2025, representing 34% and approximately $37.36 billion in value. Road transportation provides flexibility for moving pharmaceutical products between manufacturing facilities, warehouses, distribution centers, hospitals, pharmacies, and other locations. It is particularly useful for domestic and regional deliveries where shipments require frequent movement between different points in the supply chain.
Airways represented 22% of the market and are expected to grow at a relatively strong 9.49% CAGR, supported by the need for faster delivery of high-value and time-sensitive pharmaceutical products. Seaways accounted for 18%, while railways represented 9%. Storage and services contributed 17%. The increasing need for reliable, traceable, and timely pharmaceutical distribution is encouraging logistics providers to combine multiple transportation modes and improve coordination across the supply chain.
Speak to an Analystto discuss market opportunities.
Europe accounted for the largest share of the global pharmaceutical logistics market, representing 34% of total revenue and reaching USD 37.36 billion in 2025. The region continues to lead due to its established pharmaceutical manufacturing base, advanced cold-chain infrastructure, and strong regulatory standards for the transportation and storage of medicines. Growing demand for temperature-controlled logistics, biologics, and specialty pharmaceuticals is further supporting market growth.
Germany represents one of the leading pharmaceutical logistics markets in Europe, supported by its strong pharmaceutical manufacturing industry, advanced transportation infrastructure, and established cold-chain capabilities. Increasing demand for reliable distribution of temperature-sensitive medicines and biologics continues to create growth opportunities.
The UK market is supported by a well-developed pharmaceutical sector, growing demand for specialized logistics services, and increasing adoption of temperature-controlled transportation. Rising distribution requirements for specialty medicines and biologics are further contributing to market development.
Unlock Regional Insightsto access country-level data, & regional trends.
North America accounted for 30% of the global pharmaceutical logistics market, valued at USD 32.97 billion in 2025, and is projected to register the fastest CAGR of 9.48% during the forecast period. The regional market is driven by expanding pharmaceutical production, increasing demand for cold-chain logistics, and growing distribution of biologics and specialty medicines. Investments in automated warehouses, real-time shipment monitoring, and advanced supply chain technologies are further accelerating market growth.
The US market represents the largest contributor in North America, supported by its extensive pharmaceutical manufacturing and distribution network. Increasing demand for temperature-controlled transportation, specialty drug distribution, and advanced supply chain visibility solutions continues to strengthen market growth.
Canada's market is supported by increasing pharmaceutical imports and exports, expanding healthcare distribution networks, and growing demand for specialized cold-chain services. Investments in modern logistics infrastructure are also contributing to market development.
Asia Pacific accounted for 24% of the global pharmaceutical logistics market, reaching USD 26.37 billion in 2025, and is projected to grow at a CAGR of 8.96% during the forecast period. Rapid expansion of pharmaceutical manufacturing, rising healthcare expenditure, and increasing demand for medicines across emerging economies are driving regional growth. Growing investments in cold-chain infrastructure, warehouse automation, and digital supply chain technologies are further supporting market expansion.
China accounted for a significant share of the Asia Pacific market, supported by its expanding pharmaceutical manufacturing sector, growing healthcare demand, and large domestic medicine distribution network. Increasing investments in pharmaceutical warehouses, cold-chain transportation, and digital logistics platforms continue to drive market growth.
Japan's market is supported by its advanced healthcare system, established pharmaceutical industry, and strong demand for temperature-controlled logistics. Growing distribution of specialty medicines and increasing adoption of advanced supply chain technologies are contributing to market expansion.
Middle East & Africa accounted for 5% of the global pharmaceutical logistics market, totaling USD 5.49 billion in 2025. Increasing healthcare investments, expanding pharmaceutical distribution networks, and growing demand for reliable medicine transportation are supporting market growth across the region. Development of cold-chain infrastructure and improvements in healthcare supply chains are expected to create additional opportunities during the forecast period.
The UAE market is supported by its strategic location, expanding healthcare infrastructure, and growing role as a pharmaceutical distribution hub. Investments in temperature-controlled logistics, pharmaceutical warehousing, and advanced supply chain systems continue to support market development.
Africa's pharmaceutical logistics market is benefiting from expanding healthcare access, increasing pharmaceutical imports, and investments in medicine distribution infrastructure. Growing demand for reliable transportation and storage of temperature-sensitive products is creating long-term opportunities for pharmaceutical logistics providers across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Tejas Zamde is a market research professional with over 2 years of experience in the technology, semiconductor, electronics, and automotive sectors. He specializes in market assessment, competitive intelligence, industry analysis, market sizing, demand analysis, and strategic research.
His experience includes analyzing technology trends, market dynamics, regulatory developments, supply-demand patterns, value chains, and competitive landscapes across global and regional markets. He has supported clients with opportunity assessment, customer segmentation, competitive benchmarking, and growth strategy development.
Tejas combines structured research and analytical skills to translate complex industry developments into practical business insights, helping organizations identify market opportunities, assess risks, and make informed strategic decisions.
Forklift Market Size, Share, Growth, Analysis, Report, 2034
Retail Logistics Market Size, Share, Growth, Forecast, 2034
Transportation Management Systems Market Size, Share, Growth, 2034
Latin America Terminal Tractor Market Size, Share & Trends Report by 2034
Europe terminal tractor market Size & Impact analysis till 2034
Middle East and Africa Terminal Tractor Market Size, Share by 2034
We are featured on:
sales@straitsresearch.com